Sunitinib in hepatocellular carcinoma: redefining appropriate dosing, schedule, and activity end points. (Q43245401)
Jump to navigation
Jump to search
scientific article published on 9 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sunitinib in hepatocellular carcinoma: redefining appropriate dosing, schedule, and activity end points. |
scientific article published on 9 November 2009 |
Statements
Sunitinib in hepatocellular carcinoma: redefining appropriate dosing, schedule, and activity end points (English)
Chantal Dreyer
Eric Raymond
9 November 2009
e248-50; author reply e251-2